Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA: a randomised controlled trial.

Jaffer, Amir K MD (commentator)
Mant, J
Hobbs, FDR
Fletcher, K
et al,

Leonard M Miller School of Medicine, University of Miami, Miami, Florida, USA

Mant J, Hobbs FDR, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493–503.MantJHobbsFDRFletcherKet alWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA: a randomised controlled trial.Lancet2007370493-503

Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Geriatrics ★★★★★★☆ Cardiology ★★★★★★☆ Haematology ★★★★★★☆ Neurology ★★★★★★☆

For correspondence: Dr J Mant and Professor R Hobbs, University of Birmingham, Birmingham, UK; [email protected]

Source of funding: Medical Research Council (MRC).

Evidence Based Medicine 12(6):p 172, December 2007.